We have a culture that inspires intellectual curiosity and flexibility.
Counterpoint Global researches and invests across both private and public equities, and provides investment services to clients globally. The team’s public equity strategies are typically concentrated and highly differentiated from their benchmarks, with investments across the market cap spectrum in the U.S., international, and global markets. The team seeks long-term investments in unique companies whose market value can increase significantly for underlying fundamental reasons.
Strategies
| Strategy Name | Description | |
|---|---|---|
|
||
|
Invests primarily in established and emerging small cap companies in the United States.
|
||
|
Invests primarily in established and emerging mid cap companies in the United States.
|
||
|
Invests primarily in established and emerging large cap companies in the United States.
|
||
|
Invests primarily in established and emerging companies in the United States.
|
||
|
Invests primarily in established large cap companies in the United States.
|
||
|
Invests primarily in established and emerging companies globally.
|
||
|
Invests primarily in established companies in the United States that benefit from efficient scale.
|
||
|
Invests primarily in established companies globally that benefit from efficient scale.
|
||
|
||
|
Invests primarily in companies with growing intrinsic value.
|
||
|
||
|
Invests primarily in companies principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.
|
||
|
||
|
Invests primarily in established and emerging large cap companies in the United States.
|
||
Insights
Subscribe to Counterpoint Global Insights - Consilient Observer
Submit
Thank you for subscribing to Counterpoint Global Insights – Consilient Observer.